QIAGEN has introduced a new clinical test, the QIAstat-Dx Gastrointestinal Panel 2, in the US. The pricing details of the product were not disclosed. The test helps in the diagnosis of gastrointestinal infections, thus enhancing the efficiency and accuracy of diagnosis procedures.
The new test leverages QIAstat-Dx's cutting-edge technology to identify up to 16 bacterial, viral, and parasitic pathogens causing most gastrointestinal infections and uses real-time PCR technology to amplify many genetic targets, a rapid process compared to traditional microbial tests that take 1–10 days. The software interprets signals, providing positive or negative results, and an extra layer of insight via cycle threshold values and amplification curves.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.